Mesenchymal Cell-Specific MyD88 Signaling Promotes Systemic Dissemination of via Inflammatory Monocytes.

TitleMesenchymal Cell-Specific MyD88 Signaling Promotes Systemic Dissemination of via Inflammatory Monocytes.
Publication TypeJournal Article
Year of Publication2017
AuthorsKim D, Seo S-U, Zeng MY, Kim W-U, Kamada N, Inohara N, Nunez G
JournalJ Immunol
Volume199
Issue4
Pagination1362-1371
Date Published2017 08 15
ISSN1550-6606
KeywordsAnimals, Antigens, Ly, Bacterial Load, Chemokine CCL2, Immunity, Innate, Liver, Mice, Mice, Inbred C57BL, Monocytes, Myeloid Differentiation Factor 88, Salmonella Infections, Animal, Salmonella typhimurium, Signal Transduction, Spleen, Type III Secretion Systems
Abstract

Enteric pathogens including serovar can breach the epithelial barrier of the host and spread to systemic tissues. In response to infection, the host activates innate immune receptors via the signaling molecule MyD88, which induces protective inflammatory and antimicrobial responses. Most of these innate immune responses have been studied in hematopoietic cells, but the role of MyD88 signaling in other cell types remains poorly understood. Surprisingly, we found that mice with mesenchymal cell-specific deficiency of MyD88 were less susceptible to orogastric and i.p. infection than their littermates. The reduced susceptibility of mice to infection was associated with lower loads of in the liver and spleen. Mutant analyses revealed that employs its virulence type III secretion system 2 to promote its growth through MyD88 signaling pathways in mesenchymal cells. Inflammatory monocytes function as a major cell population for systemic dissemination of Mechanistically, mesenchymal cell-specific MyD88 signaling promoted CCL2 production in the liver and spleen and recruitment of inflammatory monocytes to systemic organs in response to infection. Consistently, MyD88 signaling in mesenchymal cells enhanced the number of phagocytes including Ly6CLy6G inflammatory monocytes harboring in the liver. These results suggest that promotes its systemic growth and dissemination through MyD88 signaling pathways in mesenchymal cells.

DOI10.4049/jimmunol.1601527
Custom 1

https://www.ncbi.nlm.nih.gov/pubmed/28674182?dopt=Abstract

Alternate JournalJ. Immunol.
PubMed ID28674182
PubMed Central IDPMC5548622
Grant ListR01 AI063331 / AI / NIAID NIH HHS / United States
R01 DK061707 / DK / NIDDK NIH HHS / United States
R01 DK091191 / DK / NIDDK NIH HHS / United States
T32 HL007517 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine Gale and Ira Drukier Institute for Children's Health 413 E. 69th Street New York, NY 10021